Related Experiment Video
Updated: Jun 24, 2026
05:52
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Severe congenital neutropenia
1Department of Molecular Hematopoiesis, Kinderklinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, D-30625 Hannover, Germany. welte.karl.h@mh-hannover.de
Hematology/Oncology Clinics of North America
|March 31, 2009
Summary
Congenital neutropenia (CN) is a bone marrow failure disorder causing severe bacterial infections. Acquired mutations in G-CSFR (CSF3R) are linked to leukemia development in CN patients, warranting further risk evaluation.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Congenital neutropenia (CN) is a group of disorders characterized by impaired neutrophil production.
- Patients with CN experience recurrent bacterial infections due to low neutrophil counts.
- Leukemia is a known complication in both autosomal dominant and recessive forms of CN.
Purpose of the Study:
- To investigate the genetic heterogeneity of congenital neutropenia.
- To evaluate the risk of leukemia in different genetic subtypes of CN.
- To explore the role of G-CSFR mutations in leukemogenesis in CN.
Main Methods:
- Review of existing literature on congenital neutropenia.
- Analysis of patient data regarding genetic subtypes and leukemia incidence.
- Examination of acquired G-CSFR (CSF3R) mutations in CN patients with acute myeloid leukemia.
Main Results:
- Congenital neutropenia presents with myelopoiesis arrest and low absolute neutrophil counts.
- Bacterial infections are a primary clinical manifestation from infancy.
- Acquired G-CSFR mutations are found in approximately 80% of CN patients who develop acute myeloid leukemia.
Conclusions:
- Further research is needed to assess individual risks for leukemia across CN genetic subtypes.
- Acquired G-CSFR mutations are strongly implicated in the development of leukemia in congenital neutropenia.
- Understanding the genetic basis of CN is crucial for risk stratification and management.
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:27Acute Pyelonephritis I: Introduction
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...